Goodwin practices and lawyers were honored at the 2025 LMG Life Sciences Americas Awards, which took place on September 4 in New York City. Goodwin was named Corporate Firm of the Year, Gabriela Morales-Rivera was named Corporate Attorney of the Year, and the firm won Impact Deal of the Year in Capital Markets and Venture Capital.
Goodwin's world-renowned Life Sciences practice supports the diverse needs of over 2,500 private and public companies in the biotechnology, pharmaceutical, and healthcare industries. They are also go-to advisors for top life science venture capital and investment firms. The firm's dedicated team of life sciences lawyers, strategically placed in innovation hubs across the United States, Europe, and Asia, delivers unmatched expertise and customized solutions to clients.
Gabriela Morales-Rivera is a partner in Goodwin's Life Sciences group, counseling clients in the industries of biotechnology, pharmaceuticals, and medical devices. She represents public and private companies in startup and formation matters, venture capital financing, initial public offerings and capital markets transactions, strategic investments, and other complex transactions.
Bicara Therapeutics $362 million upsized initial public offering was selected as the Impact Deal of the Year: Capital Markets. Bicara is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, and the company's shares began trading on the Nasdaq Global Market in September 2024. The Goodwin Life Sciences team advising Bicara was led by Gaby Morales-Rivera, Ryan Donahoe, Jo-an Chen, and Kingsley Taft; and included Jennifer Fay, Steve Tjoe, Matt Wetzel, Grace Wirth,Zoe Li, and Anna Roy; with invaluable assistance fromLi Chang, Frank Qin, Nathan Needle, Alex Denniston, and Maggie Wong.
Now in its 13th year, the LMG Life Sciences Americas Awards recognize the top-ranking lawyers, firms, and in-house counsel teams in the US and Canada who have had a significant impact on the life sciences industry over the past year.